A congress can bring together, within just a few hours, clinical presentations, real-world evidence data, discussions among specialists, and decisions that influence perceptions of a product or therapeutic area. For this reason, the organization of medical and scientific congresses goes beyond simply managing the venue, agenda, and registrations. It is a process in which scientific quality, compliance, traceability, and operational oversight must work together.
For pharmaceutical, biotech, and medtech companies, every congress touchpoint should be considered in terms of its overall impact. An abstract that is not aligned with the available evidence, a presentation approved too late, or an unexpected safety-related question that is not managed according to procedure can create issues that extend well beyond the event itself. Process clarity is therefore a practical measure of risk management.
Organizing Medical and Scientific Congresses: from event to controlled process
Planning should start with the objective, not the format. An advisory board, satellite symposium, national congress, or training meeting each has different purposes, audiences, levels of interaction, and requirements. Clearly defining what the event is intended to achieve, whether scientific updates, clinical discussion, insight gathering, or education on a healthcare pathway, makes it possible to build a coherent program and measure its effectiveness.
This phase requires a structured brief shared among all involved functions. Medical Affairs defines the scientific rationale and key messages; Regulatory Affairs and Quality Assurance help identify constraints and approval workflows; Marketing operates within clearly defined boundaries between corporate, scientific, and promotional communication; Pharmacovigilance functions must understand how any safety information will be identified, documented, and routed.
A common mistake is involving these functions only at the end of the planning process, when the program has already been finalized and materials are nearly complete. The result is often a fragmented review cycle, with delays, duplications, and versions that are not fully aligned. Early multidisciplinary involvement reduces late-stage corrections and strengthens document control.
The Scientific Program must answer a specific question
A comprehensive agenda is not necessarily a useful agenda. In medical and scientific congresses, the value perceived by participants depends on clinical relevance, speaker quality, and the ability to transform complex information into content that is understandable, verifiable, and applicable.
Topic selection should be based on the real needs of the scientific community: guideline updates, new clinical data, diagnostic issues, management of specific populations, prescribing appropriateness, or patient care pathways. Literature research is essential at this stage, especially when it is necessary to distinguish between established evidence, preliminary results, and hypotheses that are still under discussion.
Data, sources, and consistency of messages
Every piece of content should be supported by traceable sources and positioned appropriately within the current state of scientific knowledge. References are not merely an accessory to a presentation; they allow verification of claims, endpoints, study populations, and methodological limitations. This is particularly important when discussing indirect comparisons, observational data, subgroup analyses, or results that have not yet been fully published.
Medical writing can make a message clearer without oversimplifying its meaning. A high-quality presentation does not emphasize only favorable results; it also clearly explains the study design, context, limitations, and clinical relevance. For an expert audience, balanced information is part of credibility.
Speakers and Faculty: coordination that protects the event
Faculty members should receive clear instructions regarding objectives, target audience, timelines, required documentation, and the slide review process. The goal is not to standardize speaker style, but to ensure consistency between sessions and adherence to the agreed scientific scope.
It is useful to establish a source cut-off date, a controlled version of presentations, and clear rules for last-minute updates. If the event includes simultaneous interpretation or bilingual materials, terminology management becomes an additional point of attention. A specialized translation must preserve clinical accuracy, regulatory terminology, and the statistical meaning of the data.
Compliance and Pharmacovigilance are not subsequent activities
Congress compliance depends on the type of initiative, the stakeholders involved, funding arrangements, communication channels, and applicable company policies. There is no single checklist suitable for every event. There is, however, a consistent principle: decisions must be documented, verifiable, and proportionate to risk.
For pharmaceutical companies, the boundary between scientific information and promotional communication requires particular attention. Materials intended for healthcare professionals, engagement methods, conflict-of-interest declarations, and document management must all be assessed within the framework of applicable regulations and industry codes. In the medtech sector, the specific characteristics of the device, intended use, and communication of available evidence must also be considered.
Pharmacovigilance should be integrated into the operational plan before the event takes place. Moderators, speakers, support staff, and vendors who may receive relevant information should know how to recognize a potential adverse event report, who to forward it to, within what timeframe, and through which channels. Preparation does not require everyone to perform clinical or causality assessments. It requires ensuring that no potentially relevant information is ignored or lost.
Digital and hybrid events also require specific oversight. Chats, Q&A sessions, polls, post-event emails, and recordings may generate medical information requests, off-label questions, or safety reports. Defining in advance who monitors each channel, how evidence is retained, and how escalations are managed helps avoid grey areas during periods of greatest exposure.
Operational coordination determines perceived quality
Scientific accuracy loses effectiveness if the participant experience is fragmented. Unclear invitations, unconfirmed registrations, late agenda changes, or unavailable materials compromise the experience and increase the workload of internal teams. Effective coordination brings together scheduling, faculty management, vendors, attendee support, technology, and document workflows.
For in-person events, venue selection should also take into account confidentiality, accessibility, technical facilities, and management of spaces for parallel sessions. For digital formats, key considerations include platform reliability, moderation, access management, speaker support, and business continuity plans in case of technical issues. Hybrid events improve accessibility but increase coordination requirements. Both in-person and remote attendees must receive appropriate content, instructions, and opportunities to interact.
A detailed run of show makes it possible to manage these variables. It should clearly define responsibilities, activity sequences, timelines, escalation contacts, and contingency plans. It is not a bureaucratic document; it is the tool that enables a team to deal with unexpected situations without improvisation.
After the congress: track, respond, improve
The end of the event does not coincide with the final session. It is necessary to verify that medical information requests have been correctly routed, that any safety reports have been processed according to applicable procedures, and that materials, final versions, and operational documentation have been archived in an orderly manner.
Evaluation of outcomes should combine quantitative and qualitative data. Participant numbers, online attendance duration, questions received, and satisfaction ratings are useful indicators, but they are not sufficient. For initiatives with scientific or educational objectives, it is more important to understand which topics generated discussion, which unmet needs emerged, and whether the content reached the intended audience.
A structured debrief involving internal functions and external partners transforms experience into operational learning. It may reveal, for example, that the scientific program was effective but approval timelines were too tight, or that the digital format encouraged participation but required more intensive moderation. Such information is valuable when designing future congresses using stronger criteria.
Entrusting organization to a partner capable of integrating medical writing, literature research, specialized translations, medical information, and pharmacovigilance helps reduce the number of handoffs between different stakeholders. For organizations such as Eureka InfoMed, the value lies in bringing methodology and continuity to activities involving content with significant responsibility.
A well-organized congress is not recognized only by the absence of visible problems. It is recognized by the quality of decisions made beforehand, the traceability of activities, and the confidence with which speakers and participants are able to focus on what truly matters: scientific exchange.
Sources
- European Federation of Pharmaceutical Industries and Associations (EFPIA). EFPIA Code of Practice.
- Farmindustria. Farmindustria Code of Ethics.
- European Medicines Agency (EMA). Good Pharmacovigilance Practices (GVP), Module VI – Collection, Management and Submission of Reports of Suspected Adverse Reactions to Medicinal Products.
- International Committee of Medical Journal Editors (ICMJE). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.